Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q2 FY24 Earnings Presentation
29 slides from Apollo Hospitals Enterprise's earnings presentation, November 2023
Slide 1: Apollo Hospitals Enterprise Limited Earnings Update Q2 FY24
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q2 FY24
Slide 2: Agenda
Operational & Consolidated Healthcare Services Financial Snapshot Financials Diagnostics & Retail Digital Health Annexure Health (AHLL) & Pharmacy Distribution (Apollo HealthCo) 2
Slide 3: Operational & Financial Snapshot
Operational & Financial Snapshot 3
Slide 4: Q2FY24 Operational Snapshot
Q2FY24 Operational Snapshot Healthcare Services 44 Owned 9,155 149,197 (Hospitals) + 68% ` 57,391 / day Owned & In-patients 5 Managed Managed Occupancy ARPOB1 Hospitals Beds H1FY24: 65% H1FY24: ` 57,581 Diagnostics & 22 Retail Health Ambulatory 634 2,165 327 126 142 care & Birthing Beds Diagnostics
Slide 5: Clinical Updates/New Initiatives
o Apollomedics Super Specialty Hospital, Lucknow achieved a milestone landmark by performing 100 Successful Solid Organ Transplants. This is the only private hospital in the region to perform Cadaveric Liver & Kidney Transplants o Apollo Hospitals introduced India’s first Comprehensive Connected Car
Slide 6: Q2FY24 Financial Snapshot
Q2FY24 Financial Snapshot Revenue Growth EBITDA1 Growth EBITDA1 PAT Growth (in ₹ Mio) YoY(%) (in ₹ Mio) YoY(%) Margin (%) (in ₹ Mio) YoY(%) Healthcare Services 25,472 12% 6,345 11% 24.9% 3,136 14% Offline PD^ 17,143 14% 1,304 9% 7.6% Health Co (678) NA (387) Online PD^ & 46% (1,690)* NA 2,312 24|7 A
Slide 7: H1FY24 Financial Snapshot
H1FY24 Financial Snapshot Revenue Growth EBITDA1 Growth EBITDA1 PAT Growth (in ₹ Mio) YoY(%) (in ₹ Mio) YoY(%) Margin (%) (in ₹ Mio) YoY(%) Healthcare Services 48,409 13% 11,768 11% 24.3% 5,775 16%2 Offline PD^ 33,144 16% 2,554 11% 7.7% Health Co (1,503) NA (953) Online PD^ & 4,365 57% (3,506)* NA 2
Slide 8: Consolidated Financials
Consolidated Financials 8
Slide 9: Consolidated Financials Q2 FY24
Consolidated Financials Q2 FY24 Digital Health Overall Consolidated Revenue grew by Diagnostics & Healthcare & Pharmacy ` Mio Services Retail Health Distribution Consol 14% to ` 48,469 mio. (AHLL) (AHE) Total Revenues 25,472 3,542 19,454 48,469 • HCS Revenue grew by 12% EBITDA (Pre 24|7 Cost) 6,344
Slide 10: Consolidated Financials H1 FY24
Consolidated Financials H1 FY24 Digital Health Diagnostics & Healthcare & Pharmacy ` Mio Retail Health Consol Services Distribution Health (AHLL) HCS AHLL (AHE) Co Total Revenues 48,409 6,730 37,508 92,647 EBITDA (Pre 24|7 Cost) 11,767 550 3,060 15,377 Gross Debt 21,543 5,994 2,563 margin (%) 24.3%
Slide 11: Healthcare Services
Healthcare Services Hospitals 11
Slide 12: Consolidated Healthcare Services Performance
Consolidated Healthcare Services Performance ` Mio Q2 FY24 Q2 FY23 YoY H1 FY24 H1 FY23 YoY No of Hospitals 44 44 44 44 HCS Revenue grew by 12% in Q2FY24 ( Volume Operating beds 7765 7872 -1% 7765 7872 -1% growth of 4% price and case mix of 8%). Occupancy 68% 68% 65% 64% Self pay and Insurance grew b
Slide 13: Region wise Operational Parameters Q2FY24
Region wise Operational Parameters Q2FY24 Tamilnadu Region AP, Telengana Region Karnataka Region Total (7) (1) (2) (3) (Chennai & ROTN) (Hyderabad & others) (Bangalore & others) Particulars Q2 FY 23 Q2 FY 24 yoy (%) Q2 FY 23 Q2 FY 24 yoy (%) Q2 FY 23 Q2 FY 24 yoy (%) Q2 FY 23 Q2 FY 24 yoy (%) No. of
Slide 14: Region wise Operational Parameters H1FY24
Region wise Operational Parameters H1FY24 Tamilnadu Region AP, Telengana Region Karnataka Region Total (7) (1) (2) (3) (Chennai & ROTN) (Hyderabad & others) (Bangalore & others) Particulars H1 FY 23 H1 FY 24 yoy (%) H1 FY 23 H1 FY 24 yoy (%) H1 FY 23 H1 FY 24 yoy (%) H1 FY 23 H1 FY 24 yoy (%) No. of
Slide 15: Strong ROCE across Metros and Non Metros
Strong ROCE across Metros and Non Metros Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi Non Metros (includes Tier1 & Tier2 cities) Metros Non Metros Ahmedabad, Bhubaneshwar, Lucknow, Indore Guwahati, Madurai, Trichy, Nellore,Vizag, Mysore, Nashik, Bilaspur, Karimnagar, Karur, Karai
Slide 16: Healthcare Services: Expansion Plan
Healthcare Services : Expansion Plan Total Census Project Cost Project Nature Remarks Beds Beds (in Crs) Expected commisioning : FY25 Gachibowli, Hyderabad Greenfield - Asset Light 375 300 ₹ 370 Q4 FY25 Bangalore Brownfield 150 110 ₹ 150 Q4 FY25 Sonarpur Kolkata Hospital Asset Acquisition 220 180 ₹
Slide 17: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 17
Slide 18: Executive Summary
Executive Summary ➢ TG-specific service lines being formulated based on micro-market environment Primary Care ➢ Focus on deep community connect and engagement ➢ Corporate empanelment via customized portals for better utilization of employee benefits ➢ Rapid expansion of PCC network (400+ Centres in
Slide 19: Financial Performance Q2FY24
Financial Performance Q2FY24 Q2 FY24 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) AHLL Core Revenues (excluding Covid Network 327 2,165 66 142 126 11 17 11 Vaccination, Covid Testing and Isolation Footfalls/Day* 2,681 15,943 528 242 1,938 57 45 75 Centre Revenues which wer
Slide 20: Financial Performance H1FY24
Financial Performance H1FY24 H1 FY24 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) AHLL revenues grew by 10% from H1FY 24 Network 327 2,165 66 142 126 11 17 11 Footfalls/Day* 2,470 15,024 500 233 1,894 52 36 73 Gross ARPP (Rs.)* 2,055 749 3,103 6,380 1,617 103,997 39,197 10
Slide 21: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 EBITDA (INR Mn)2 Operational footprint 1,239 (as of Sept 30, 2023) 1,040 1,031 1,075 3 940 15 16 14% ~300 118 24 12% Cities 1,236 5% 7% presence 1,016 1,059 148 5% 149 922 916 75 50 51 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 Q2 FY23 Q3 FY23 Q4 FY2
Slide 22: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 22
Slide 23: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare Platform Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at September 30, 2023 Q2 24 107 ~29 Mn+ ~8.8 Lakh ~6,261 Closed 09 Registrations Daily Active Users Doctors Q2 24 Chandigarh: 5 Net 98 Doctor Consultation Daily Consultation Himachal Prade
Slide 24: Apollo HealthCo Financials Q2 FY24
Apollo HealthCo Financials Q2 FY24 Online Pharmacy Healthco ( Q2’FY 24 vs Q1’FY 24) : Offline Pharmacy Total Health ` Mio Distribution & Distribution Co Apollo 247 o 8% growth in revenue in Q2’ FY24 vs Q1’ FY24 Total Revenues 17,143 2,312 19,454 o 32% reduction in EBITDA losses in Q2’ FY24 (Rs 387 M
Slide 25: Apollo HealthCo Financials H1FY24
Apollo HealthCo Financials H1FY24 Healthco : Online Pharmacy Offline Pharmacy Total Health ` Mio Distribution & Distribution Apollo 247 Co o Platform GMV : Rs 13,486 Mn in H1’ FY24, growth of 165% over H1’ FY23 o 19% growth in revenue in H1’ FY24 vs H1’ FY23 Total Revenues 33,143 4,365 37,508 o 31%
Slide 26: Annexure
Annexure 26
Slide 27: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai Chennai Apollo Hea
Slide 28: IND AS 116: Impact on P&L and Balance Sheet – Q2FY24
` Mio IND AS - 116 : Impact on P&L and Balance Sheet – Q2FY24 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 7,699 Revenue Right of use 14,685 Revenue Asset Asset Other 228 Other as of as of 538 expenses 30th
Slide 29: Thank you !
Thank you ! 29
Apollo Hospitals Enterprise — Q2 FY24 Earnings Presentation on 6ix